Annals of dermatology

  • 제30권6호
  • /
  • Pages.721-724
  • /
  • 2018
  • /
  • 1013-9087(pISSN)
  • /
  • 2005-3894(eISSN)
대한피부과학회 (Korean Dermatological Association)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Value of Leukocytosis in Systemic Anaplastic Large-Cell Lymphoma with Cutaneous Involvement

  • Lim, Youngkyoung (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Ji-Hye (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Dong-Youn (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2017.10.20
  • 심사 : 2017.12.11
  • 발행 : 2018.12.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Lee WJ, Moon IJ, Lee SH, Won CH, Chang SE, Choi JH, et al. Cutaneous anaplastic large-cell lymphoma (ALCL): a comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site. J Am Acad Dermatol 2016;74:1135-1143. https://doi.org/10.1016/j.jaad.2015.12.053
  2. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the international peripheral T-cell lymphoma project. Blood 2008;111:5496-5504. https://doi.org/10.1182/blood-2008-01-134270
  3. Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology (Williston Park) 2010;24:574-587.
  4. Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol 2013;85:206-215. https://doi.org/10.1016/j.critrevonc.2012.06.004
  5. Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol 2012;83:293-302. https://doi.org/10.1016/j.critrevonc.2012.02.005
  6. Rochet NM, Markovic SN, Porrata LF. The role of complete blood cell count in prognosis-watch this space. Oncol Hematol Rev 2012;8:76-82.
  7. Chang IW, Chen HK, Ma MC, Huang WT. Anaplastic large cell lymphoma with paraneoplastic leukocytosis: a clinicopathological analysis of five cases. APMIS 2011;119:794-801. https://doi.org/10.1111/j.1600-0463.2011.02811.x
  8. Kim HS, Sim SJ, Kim DC, Kim JS, Song KH, Kim KH. A case of ALK-negative systemic anaplastic large cell lymphoma. Ann Dermatol 2004;16:125-131. https://doi.org/10.5021/ad.2004.16.3.125
  9. El-Osta HE, Salyers WJ, Jr, Palko W, Hagan ME, El-Haddad B, Schulz TK. Anaplastic large-cell lymphoma with leukemoid reaction. J Clin Oncol 2008;26:4356-4358. https://doi.org/10.1200/JCO.2008.17.3906
  10. Sueki Y, Nozaki Y, Kawashima I, Yamamoto T, Nakajima K, Mitumori T, et al. Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression. Int J Hematol 2014;99:773-776. https://doi.org/10.1007/s12185-014-1557-3